I dont believe cancer vaccines are in the interest of GSK.
That was a reply I got around 6 - 8 months back when I highlighted PRR to Christopher Francis at GSK, who heads up the Oncology business development unit. Maybe times have changed or that was a throw away line..........
See the attached link and feel free to email him:
www.gsk.com/collaborations/downloads/WWBD-mini-brochure.pdf
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $374.3M | |||
| Open | High | Low | Value | Volume |
| 25.5¢ | 26.0¢ | 25.0¢ | $688.7K | 2.700M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 591471 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 781559 | 1 |
View Market Depth
| Last trade - 16.10pm 22/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |